Free Trial

Aquestive Therapeutics (AQST) SEC Filings & 10K Form

Aquestive Therapeutics logo
$2.35 +0.06 (+2.62%)
Closing price 05/23/2025 04:00 PM Eastern
Extended Trading
$2.36 +0.01 (+0.43%)
As of 05/23/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Aquestive Therapeutics SEC Filings

DateFilerForm TypeView
05/07/2025
8:10 AM
Aquestive Therapeutics (Issuer)
Cioffi Melina (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/25/2025
3:31 PM
Aquestive Therapeutics (Filer)
Form DEF 14A
04/25/2025
3:33 PM
Aquestive Therapeutics (Filer)
Form DEFA14A
04/25/2025
3:34 PM
Aquestive Therapeutics (Filer)
Form ARS
04/01/2025
7:26 AM
Aquestive Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/11/2025
4:47 PM
Aquestive Therapeutics (Issuer)
Barber Daniel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
4:47 PM
Aquestive Therapeutics (Issuer)
Boyd Peter E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
4:47 PM
Aquestive Therapeutics (Issuer)
BRAENDER LORI J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
4:48 PM
Aquestive Therapeutics (Issuer)
Korczynski Sherry (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
4:48 PM
Aquestive Therapeutics (Issuer)
Kraus Carl N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
4:48 PM
Aquestive Therapeutics (Issuer)
TOTH A ERNEST JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
4:48 PM
Aquestive Therapeutics (Issuer)
Jung Cassie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
4:49 PM
Aquestive Therapeutics (Issuer)
Wargacki Stephen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
7:10 AM
Aquestive Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/05/2025
3:29 PM
Aquestive Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/14/2025
5:12 PM
Aquestive Therapeutics (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
Form SCHEDULE 13G/A
02/13/2025
10:38 AM
Aquestive Therapeutics (Subject)
BRATTON DOUGLAS K (Filed by)
Form SCHEDULE 13G/A
02/12/2025
6:22 AM
Aquestive Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/24/2025
3:51 PM
Aquestive Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
01/13/2025
6:07 AM
Aquestive Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/19/2024
7:02 AM
Aquestive Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/02/2024
7:08 AM
Aquestive Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2024
3:40 PM
Aquestive Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2024
3:42 PM
Aquestive Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/25/2024
7:05 AM
Aquestive Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/24/2024
7:06 AM
Aquestive Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/22/2024
5:06 PM
Aquestive Therapeutics (Subject)
BlackRock, Inc. (Filed by)
Form SC 13G
10/16/2024
4:16 PM
Aquestive Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/02/2024
1:14 PM
Aquestive Therapeutics (Issuer)
Jung Cassie (Reporting)
Form 4/A
10/02/2024
1:15 PM
Aquestive Therapeutics (Issuer)
Barber Daniel (Reporting)
Form 4/A
10/02/2024
1:15 PM
Aquestive Therapeutics (Issuer)
Wargacki Stephen (Reporting)
Form 4/A
10/02/2024
1:16 PM
Aquestive Therapeutics (Issuer)
Schobel Alexander Mark (Reporting)
Form 4/A
09/27/2024
7:46 AM
Aquestive Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/09/2024
7:56 AM
Aquestive Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2024
7:08 AM
Aquestive Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2024
1:45 PM
Aquestive Therapeutics (Issuer)
Kraus Carl N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2024
3:26 PM
Aquestive Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/25/2024
7:16 AM
Aquestive Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/21/2024
3:32 PM
Aquestive Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/21/2024
12:51 PM
Aquestive Therapeutics (Issuer)
MORRIS TIMOTHY E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2024
12:50 PM
Aquestive Therapeutics (Issuer)
COSTA SANTO J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Musk’s AI Masterplan – Our #1 AI Stock to Buy Now (Ad)

Missed Nvidia? This Under-the-Radar AI Stock Could Be Next Musk's AI empire is just beginning — and one overlooked company could be at the center of it all. We reveal everything in this exclusive Memorial Day webinar.

Reserve your spot before it's gone >>>
06/21/2024
12:50 PM
Aquestive Therapeutics (Issuer)
Cochran John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2024
12:50 PM
Aquestive Therapeutics (Issuer)
Krop Julie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2024
12:51 PM
Aquestive Therapeutics (Issuer)
BROWN GREGORY B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2024
12:51 PM
Aquestive Therapeutics (Issuer)
Taglietti Marco (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2024
4:14 PM
Aquestive Therapeutics (Issuer)
Korczynski Sherry (Reporting)
Form 3/A
06/11/2024
11:35 AM
Aquestive Therapeutics (Issuer)
Korczynski Sherry (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/11/2024
11:36 AM
Aquestive Therapeutics (Issuer)
Korczynski Sherry (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
7:13 AM
Aquestive Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:AQST) was last updated on 5/24/2025 by MarketBeat.com Staff
From Our Partners